Analgesic effect of antidepressant drugs

Pharmacology Biochemistry and Behavior

Volumn 59, Issue 2, 1998, Pages 331-338

  Korzeniewska Rybicka, Iwona ^a   Płänik, Adam ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Analgesia; Antidepressants; Porsolt test; Rats; Writhing test

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; CITALOPRAM; IMIPRAMINE; MAPROTILINE;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NOCICEPTION; NONHUMAN; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SHOCK; TAIL FLICK TEST; WRITHING TEST;

ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENCE POLARIZATION IMMUNOASSAY; MALE; MOTOR ACTIVITY; PAIN MEASUREMENT; RATS; RATS, WISTAR; REACTION TIME;

EID: 0032005745     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(97)00336-5     Document Type: Article

References (55)

1. Ageel A. M. Effects of desipramine and chlorimipramine on buprenorphine analgesia in mice. Jpn. J. Pharmacol. 41:1986;139-145.
2. Ansuategui M., Naharro L., Feria M. Noradrenergic and opioidergic influences on the antinociceptive effect of clomipramine in the formalin test in rats. Psychopharmacology (Berlin). 98:1989;93-96.
3. Ardid D., Eschalier A., Lavarenne J. Evidence for a central but not a peripheral analgesic effect of clomipramine in rats. Pain. 45:1991;95-100.
4. Ardid D., Guilbaud G. Antinociceptive effects of acute and chronic injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain. 49:1992;279-287.
5. Ardid D., Jourdan D., Mestre Ch., Villanueva L., Le Bars D., Eschalier A. Involvement of bulbospinal pathways in the antinociceptive effect of clomipramine in the rat. Brain Res. 695:1995;253-256.
6. Ardid D., Marty H., Fialip Y., Privat A. M., Eschalier A., Lavarenne Y. Comparative effects of different uptake inhibitor antidepressants in two pain tests in mice. Fundam. Clin. Pharmacol. 6:1992;78-82.
7. Basbaum A. I., Fields H. L. Endogenous pain control systems. Brainstem spinal pathways and endorphin circuitry Annu. Rev. Neurosci. 7:1984;309-338.
8. Besson J. M., Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67:1987;67-186.
9. Bianchi M., Sacerdote P., Panerai A. E. Chlomipramine differently affects inflammatory edema and pain in the rats. Pharmacol. Biochem. Behav. 48:1994;1037-1040.
10. Bianchi M., Panerai A. E Antidepressant drugs and experimental inflammation. Pharmacol. Res. 33:1996;235-238.
11. Biegon A., Samuel D. Interaction of tricyclic antidepressants with opiate receptors. Biochem. Pharmacol. 29:1980;460-462.
12. Bite A., Gyorgy L. Studies on the potentiation of antinociceptive effect of oxotremorine by tetrabenazine in mice. Psychopharmacology (Berlin). 34:1974;63-70.
13. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. 37:1995;377-395.
14. Botney M., Fields H. L. Amitriptyline potentiates morphine analgesia by direct action on central nervous system. Ann. Neurol. 13:1983;160-164.
15. Bromm B., Meier W., Scharein W. Imipramine reduces experimental pain. Pain. 25:1986;245-257.
16. Butler S. H., Weil-Fugazza J., Godefroy F., Besson J. M. Reduction of arthritis and pain behavior following chronic administration of imipramine and amitriptyline in rats with adjuvant-induced arthritis. Pain. 23:1985;159-175.
17. Codd E. E., Shank R. P., Schupsky J. J., Raffa R. B. Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics. Structural determinants and role in antinociception J. Pharmacol. Exp. Ther. 273:1995;1263-1269.
18. Coquoz D., Porchet H., Dayer P. Central analgesic effects of desipramine, fluvoksamine, and moclobemide after single oral dosing. A study in healthy volunteers Clin. Pharmacol. Ther. 54:1993;339-344.
19. Danysz W., Płanik A., Kostowski W., MalatyÒska E., Torbjorn C., Jarbe C., Hiltunen A. J., Archer T. Comparison of d desipramine, amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugs. Pharmacol. Toxicol. 62:1989;42-50.
20. De Felipe M., De Caballos M., Fuenties J. A. Hypoalgesia induced by antidepressants in mice. A case for opioids and serotonin Eur. J. Pharmacol. 125:1986;193-199.
21. Dirkensen R., Van Diejen D., Van Luijtelaar E. L. J. M., Booij L. H. D. J. Site- and test-dependent antinociceptive efficacy of amitriptyline in rats. Pharmacol. Biochem. Behav. 47:1994;21-26.
22. Eide K., Hole K. Acute and chronic treatment with selective serotonin uptake inhibitors in mice. effects on nociceptive sensitivity and response to 5-methoksy-N,N-dimethyltryptamine Pain. 32:1988;333-340.
23. Eschalier A., Montastruc J. L., Devoize J. L., Rigal F., Gaillard- Plaza G., Pechadre J. C. Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats. Eur. J. Pharmacol. 74:1981;1-7.
24. Eschalier A., Fialip J., Varoquaux O., Makambila M. C., Marty H., Bastide P Pharmacokinetic patterns of repeated administration of antidepressants in animals. Implication for antinociceptive action of clomipramine in mice. J. Pharmacol. Exp. Ther. 245:1988;963-968.
25. Eschalier A. Antidepressants and pain management. Besson J. M. Excerpta Medica. Proceedings of the international symposium on serotonin and pain:1990;305-325 Elsevier Science Publishers, Amsterdam.
26. Eschalier A., Mestre Ch., Dubray C., Ardid D. Why are antidepressants effective as pain relief? CNS Drugs. 2:1994;261-267.
27. Feinmann Ch. Pain relief by antidepressants. Possible modes of action Pain. 23:1985;1-8.
28. Fialip J., Marty H., Aumaitre O., Bougerolle A. M., Dordain G., Berger J. A., Eschalier A. Antinociceptive activity of metapramine in mice. Relationship with its pharmacokinetic properties. Life Sci. 50:1992;161-168.
29. Hunskaar S. Similar effects of acetylsalicylic acid and morphine on immediate response to acute noxious stimulation. Pharmacol. Toxicol. 60:1987;167-170.
30. Isenberg K., Cicero T. J. Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds. Eur. J. Pharmacol. 103:1984;57-63.
31. Kuraishi Y., Harada Y., Takagai H. Noradrenaline regulation of pain-transmission in the spinal cord mediated by alfa-adrenoceptors. Brain Res. 174:1979;333-336.
32. Lance J. W., Curran D. A. Treatment of chronic tension headache. Lancet. 1:1964;1235-1238.
33. Lee R., Spencer P. S. J. Antidepressants and pain. A review of the pharmacological data supporting the use certain tricyclics in chronic pain. J. Intern. Med. Res. 5:1977;146-156.
34. Michael-Titus A., Costentin J. Analgesic effects of metapiramine and evidence against the involvement of endogenous enkephalins in the analgesia induced by tricyclic antidepressants. Pain. 31:1987;391-400.
35. Onghena P., Van Houdenhove B. Antidepressant-induced analgesia in chronic nonmalignant pain. A meta-analysis of 39 placebo-controlled studies Pain. 49:1992;205-219.
36. Płanik A., Kostowski W., Archer T Serotonin and depression. Old problems and new data Prog. Neuropsychopharmacol. Biol. Psychol. 13:1989;623-633.
37. Porsolt R. D., Bertin A., Jalfre M. Behavioural despair in mice. A primary screening test for antidepressants Arch. Int. Pharmacodyn. 229:1977;327-336.
38. Porsolt R. D., Anton G., Blavet N., Jalfre M. Behavioral despair in rats. A new model sensitive to antidepressant treatments Eur. J. Pharmacol. 47:1978;379-391.
39. Poulsen L., Arendt-Nielsen L., Broesen K., Nielsen K. K., Gram L. F., Sindrup H. S. The hypoalgesic effect of imipramine in different human experimental pain models. Pain. 60:1995;287-293.
40. Reddy S. V. R., Yaksh T. L. Spinal noradrenergic terminal system mediates antinociception. Brain Res. 189:1980;391-401.
41. Reichenberg K., Gaillard-Plaza G., Montastruc J. L. Influence of naloxone on the antinociceptive effects of some antidepressant drugs. Arch. Int. Pharmacodyn. Ther. 275:1985;78-85.
42. Richelson E. Pharmacology of antidepressants. Psychopharmacology (Berlin). 20(Suppl. 1):1987;1-12.
43. Rigal R., Eschalier A., Devoise J. L., Pechardre J. C. Activities of five antidepressants in a behavioral pain tests in rats. Life Sci. 32:1983;2965-2971.
44. Rosenblatt R. M., Reich J., Dehring D. Tricyclic antidepressants in treatment of depression and chronic pain. Analysis of the supporting evidence. Anesth. Analg. 63:1984;1025-1032.
45. Sierralta F., Pinardi G., Mendez M., Miranda H. F. Interaction of opioids with antidepressant-induced antinociception. Psychopharmacology (Berlin). 122:1995;374-378.
46. Sierralta F., Pinardi G., Miranda H. F. Effect of p-chlorophenylalanine and alfa-methyltyrosine on the antinociceptive effect of antidepressant drugs. Pharmacol. Toxicol. 77:1995;276-280.
47. Sjoquist F., Bertilsson L. Clinical pharmacology of antidepressant drugs. Pharmacogenetics Usdin E. Frontiers in biochemical and pharmacological research in depression. 1984;359-374 Raven Press, New York.
48. Spiegel K., Kalb R., Pasternak G. V. Analgesic activity of tricyclic antidepressants. Ann. Neurol. 13:1983;462-465.
49. Theobald V. W., Buch O., Kunz H. A., Morpurgo C. Zur pharmacologie der antidepressivum 3-chloro-5-(3-dimethylaminopropyl)-10,11-dihydro-5H-dibenz(b,f)azepin. Arzneimeittleforschung. 17:1967;561-568.
50. Toffanetti O., Albiero L., Galatulas I., Genovese E. Enhancement of propoxyphene-induced analgesia by doxepin. Psychopharmacology (Berlin). 51:1977;213-215.
51. Tura B., Tura S. M. The analgesic effect of tricyclic antidepressants. Brain Res. 518:1990;19-22.
52. Walsh D. Antidepressants in chronic pain. Clin. Neuropharmacol. 6:1983;271-295.
53. Watson C. P. N. Antidepressant drugs as adjuvant analgesics. J. Pain. Symptom. Manage. 9:1994;392-405.
54. Valverde O., Mico J. A., Maldonado M., Mellado M., Gibert-Rahola J. Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioral pain tests in mice. Prog. Neuro-psychopharmacol. Biol. Psychiatry. 18:1994;1073-1092.
55. Yaksh T. L., Wilson P. R Spinal serotonin terminal system mediates antinociception. J. Pharmacol. Exp. Ther. 208:1979;446-453.